CardiASK tabs 100mg #60

CardiASK user manual

Reed more and buy CardiASK pills on this page

Composition

The active substance of the drug is acetylsalicylic acid.
In addition, it contains the following additional components: stearic acid, lactose monohydrate, povidone, MCC, maize starch, castor oil hydrogenated, tween 80.
The film membrane of the drug consists of: methacrylic acid and copolymer of ethyl acrylate, copovidone, talc, macrogol and copolymer of polyvinyl alcohol, triethyl citrate, titanium dioxide.

Form of issue

Produced in the form of tablets of 50 and 100 mg.

pharmachologic effect

Has anti-aggregation effect. In addition, it has anti-inflammatory, analgesic and antipyretic properties.

Pharmacodynamics and pharmacokinetics

The irreversible inactivation of COX-1 inhibits the synthesis of thromboxane A2 and reduces the aggregation of platelets.
The drug is sucked in the small intestine. The maximum concentration of active substance in the blood plasma occurs 3 hours after application. It is partially cleaved in the liver with the formation of inactive metabolites.
This drug is excreted through the kidneys in an unchanged form, as well as in the form of metabolites. The half-life is 15 minutes for the active substance and 3 hours for the metabolites.

Indications for use CardiASK

Indications for use CardiASK are as follows:
    prevention of acute myocardial infarction (especially in the presence of diabetes, hypertension, hyperlipidemia, obesity, as well as in old age);
    prevention of ischemic stroke;
    prevention of thromboembolism after invasive vascular interventions, as well as operations;
    angina pectoris;
    prevention of cerebral circulation disorders;
    prevention of deep vein thrombosis;
    prevention of thromboembolism of the pulmonary artery and its branches.

Contraindications

The drug is not recommended for:
    ulcerative lesion of the gastrointestinal tract;
    problems with kidney function;
    bronchial asthma;
    hypersensitivity to one or more components of the drug;
    bleeding in the gastrointestinal tract;
    hemorrhagic diathesis;
    hepatic and renal insufficiency;
    pregnancy;
    lactation;
    childhood.

Side effects

When using the drug, there were side effects such as nausea, vomiting, heartburn, abdominal pain, dizziness, headache, hearing loss, tinnitus. In rare cases, ulcers of the stomach and small intestine, as well as violations in the liver with increased activity of transaminases, bleeding in the gastrointestinal tract, anemia.
It is also possible occurrence of rash, urticaria, allergic rhinitis, anaphylaxis, pruritus, angioedema, swelling of the nasal mucosa and cardiorespiratory distress syndrome.

Instructions for use CardiASK

The drug is used inside before eating. Tablets should be washed down with plenty of water.
Instructions for use CardiASK provides an individual dosing regimen:
    for adults, a single dosage can be from 150 mg to 2 g, and daily, in turn, from 150 mg to 8 g. The drug is taken 2-6 times a day;
    for children, a single dose of 10-15 mg per kilogram. Tablets are taken up to 5 times a day;
    with acute myocardial infarction, as well as for the prevention of stroke and cerebral circulation disorders, it is recommended to take 100 mg of the drug per day.
The final dosage and use chart should be agreed with the doctor. Instructions for use CardiASK reports that the drug is intended for long-term use. The duration of the course is also determined by the doctor.

Overdose

In case of overdose, nausea, tinnitus, dizziness, vomiting, deterioration of hearing, confusion may occur. At very high doses, fever, ketoacidosis, coma, severe hypoglycemia, hyperventilation, respiratory alkalosis, as well as cardiovascular and respiratory failure appear.
Symptoms of overdose are especially evident in patients in old age.
In case of an overdose of moderate severity, the dose of the drug is reduced. In case of severe overdose, the patient should immediately be hospitalized and carry out emergency therapy. Assign gastric lavage and activated carbon, alkaline and alkaline forced diuresis (indices necessary to achieve a pH of 7.5-8), fluid therapy, determination of acid-base equilibrium dialysis. Treatment is symptomatic.

Interaction

This drug enhances the effect of the following drugs:
    methotrexate;
    thrombolytics and antiplatelet agents;
    hypoglycemic agents;
    heparin and indirect anticoagulants;
    digoxin;
    valproic acid.
Side effects from the hematopoiesis can occur with a combination of CardiASK with Methotrexate, anticoagulants, antiaggregants, thrombolytics.
The drug also reduces the effect of uricosuric medicines: Benzbromarone, diuretics, ACE inhibitors.

Terms of sale

To buy CardiASK the prescription is not required.

Storage conditions

Keep the drug out of the reach of children, dry and well protected from light penetration. The optimum temperature is not higher than 25 ° C.
Shelf life is 2 years.

Reviews

Reviews about the drug CardiASK are mostly positive. At the forums, many are interested in whether this tool is more effective than its counterparts. There is no single answer to this question, since there are a lot of similar drugs and all of them have their own peculiarities.
Reviews of specialists about CardiASK are also positive. Very often they prescribe it for the prevention of myocardial infarction, stroke and thrombosis of various etiologies.